These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28800545)

  • 1. Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection.
    Liu Y; Li ZY; Li X; Wang JN; Huang QA; Huang Y
    Breast; 2017 Oct; 35():191-195. PubMed ID: 28800545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients.
    Liu Y; Li ZY; Wang JN; Li X; Huang QA; Huang Y
    Breast Cancer Res Treat; 2017 Jul; 164(2):379-383. PubMed ID: 28447238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
    Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
    Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Talima S; Kassem H; Kassem N
    Breast Cancer; 2019 Mar; 26(2):154-163. PubMed ID: 30191397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
    Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
    Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
    J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.
    Levaggi A; De Maria A; Dozin B; Iacono G; Bighin C; Giraudi S; Lambertini M; D'Alonzo A; Poggio F; Pronzato P; Del Mastro L
    Anticancer Res; 2014 Jul; 34(7):3715-20. PubMed ID: 24982392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of chronic hepatitis in children with cancer.
    Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
    Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rancewicz Z; Rowińska D; Kozłowska-Boszko B; Wyzga J; Walewska-Zielecka B; Rowiński W; Szmidt J; Lao M
    Ann Transplant; 1996; 1(2):11-2. PubMed ID: 9869922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
    Lee HJ; Kim DY; Keam B; Lee JH; Han SW; Oh DY; Yoon JH; Kim TY; Kim YJ; Lee KW; Kim JW; Jeong SH; Lee JS; Kim JH; Im SA
    Breast Cancer; 2014 Jul; 21(4):387-93. PubMed ID: 23073741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection.
    Shoji H; Hashimoto K; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Tamura K; Ando M; Fujiwara Y
    Oncology; 2012; 82(4):228-33. PubMed ID: 22508294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.
    Dai MS; Wu PF; Lu JJ; Shyu RY; Chao TY
    Support Care Cancer; 2004 Mar; 12(3):191-6. PubMed ID: 15074316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.
    Kim E; Yune S; Ha JM; Lee WJ; Hwang JW; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2014 Sep; 61(134):1704-11. PubMed ID: 25436366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.